KIT c.2451C>G ;(p.I817M)

Variant ID: 4-55599325-C-G

NM_000222.2(KIT):c.2451C>G;(p.I817M)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.

Cancer Medicine
Zhou, Ye Y; Zhang, Xinhua X; Wu, Xiaojun X; Zhou, Yongjian Y; Zhang, Bo B; Liu, Xiufeng X; Wu, Xin X; Li, Yan Y; Shen, Lin L; Li, Jian J
Publication Date: 2020-09

Variant appearance in text: KIT: I817M
PubMed Link: 32677196
Variant Present in the following documents:
  • Main text
  • CAM4-9-6225.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: KIT: I817M
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page